Published in Medical Letter on the CDC and FDA, July 1st, 2001
"Decisions about the dissemination of HIV interventions need to be informed by evidence of their cost-effectiveness in reducing negative health outcomes," M. Sweat and colleagues at Johns Hopkins University say.
Sweat and coworkers showed that the "Voices/Voces" program is an effective and efficient use of health care dollars, with savings from disease prevention far outweighing the expenditures needed...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA